Baseline characteristics of patients receiving either dihydroartemisinin-piperaqine (DP) or artemether-lumefantrine (AL)
收藏NIAID Data Ecosystem2026-03-06 收录
下载链接：
https://figshare.com/articles/dataset/_Baseline_characteristics_of_patients_receiving_either_dihydroartemisinin_piperaqine_DP_or_artemether_lumefantrine_AL_/600120
下载链接
链接失效反馈官方服务：
资源简介：
Baseline characteristics of patients receiving either dihydroartemisinin-piperaqine (DP) or artemether-lumefantrine (AL)
接受双氢青蒿素哌喹（dihydroartemisinin-piperaqine，DP）或蒿甲醚-本芴醇（artemether-lumefantrine，AL）治疗的患者的基线特征
创建时间：
2008-06-11
